AT

Aneesh Tyagi

Director Director DIN 09771065
DIN 09771065 First appointment Oct 2022 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2022
Shareholding value •••• Premium profile

About Aneesh Tyagi

Data last updated:

Aneesh Tyagi was a Director at Alnova Pharma Private Limited (2023–2025) and Director at Va Medi Pharma Private Limited (2022–2023). The companies operate in Paper and Chemicals.

DIN 09771065
Primary Designation Director
Industry Paper
First Appointment 19 Oct 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alnova Pharma Private Limited U21001HR2023PTC111030
Director24 Apr 20232023Active
Va Medi Pharma Private Limited U24290HR2022PTC107301
Director19 Oct 20222022₹1.1 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alnova Pharma Private Limited
Va Medi Pharma Private Limited
Premium access

Shareholding and investment profile for Aneesh Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aneesh Tyagi

Aneesh Tyagi was first appointed on 19 Oct 2022 as Director at Va Medi Pharma Private Limited. The most recent appointment on record is 24 Apr 2023 at Alnova Pharma Private Limited.

Aneesh Tyagi held 2 earlier board appointments: Alnova Pharma Private Limited (Director, 24 Apr 2023 to 30 May 2025); Va Medi Pharma Private Limited (Director, 19 Oct 2022 to 30 May 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available